APTEVO THERAPEUTICS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 03835L702 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Niowave, Inc. 13G	12.2%	151,723	13G	6/22/2026 Event 5/25/2026
CVI Investments, Inc. 13G/A	6.3%	83,854	13G/A	8/14/2026 Event 6/30/2026
CVI Investments, Inc.	6.3%	83,854
Heights Capital Management, Inc.	6.3%	83,854

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	9	50.4 k	$224 k	$0
2026 Q1	9	53.8 k	$230 k	$0
2025 Q4	11	20.3 k	$191 k	$0
2016 Q4	1	6.00	$15.00	$0
2016 Q3	1	6.00	$15.00	$0